118 related articles for article (PubMed ID: 36184212)
1. Burden of non-communicable chronic diseases attributable to the consumption of sugar-sweetened beverage, 1990-2019.
Leal JSV; Vegi ASF; Meireles AL; Machado ÍE; Menezes MC
Clin Nutr ESPEN; 2022 Oct; 51():253-261. PubMed ID: 36184212
[TBL] [Abstract][Full Text] [Related]
2. The burden of ischemic heart disease and type 2 diabetes mellitus attributable to diet high in sugar-sweetened beverages in China: An analysis for the Global Burden of Disease Study 2017.
Li M; Li X; Zhao Y; Zhang L; Yang J; Zhou M; Wang Z
J Diabetes; 2021 Jun; 13(6):482-493. PubMed ID: 33151626
[TBL] [Abstract][Full Text] [Related]
3. Health economic impacts associated with the consumption of sugar-sweetened beverages in Brazil.
Leal JSV; Fogal AS; Meireles AL; Cardoso LO; Machado ÍE; de Menezes MC
Front Nutr; 2022; 9():1088051. PubMed ID: 36601075
[TBL] [Abstract][Full Text] [Related]
4. Health and economic burden of sugar-sweetened beverages consumption in Brazil.
Perelli L; Alcaraz A; Vianna CMM; Espinola N; Cairoli FR; Bardach A; Palacios A; Balan D; Johns P; Augustovski F; Pichón-Rivière A
Cad Saude Publica; 2023; 39(12):e00249422. PubMed ID: 38126558
[TBL] [Abstract][Full Text] [Related]
5. Global disease burden attributed to high sugar-sweetened beverages in 204 countries and territories from 1990 to 2019.
Sun H; Liu Y; Xu Y; Gong X; Zhai C; Hu W; Wang Y; Zong Q; Yu G; Wang L; Yan Z; Zhang T; Wang F; Zou Y
Prev Med; 2023 Oct; 175():107690. PubMed ID: 37659613
[TBL] [Abstract][Full Text] [Related]
6. Global burden of ischemic heart disease attributable to high sugar-sweetened beverages intake from 1990 to 2019.
Wang L; Ma N; Wei L
Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1190-1196. PubMed ID: 37032253
[TBL] [Abstract][Full Text] [Related]
7. Sugar-sweetened beverage taxes in Brazil: past, present, and future.
Bridge G; Groisman S; Bedi R
J Public Health Policy; 2022 Jun; 43(2):281-291. PubMed ID: 35190661
[TBL] [Abstract][Full Text] [Related]
8. Impact of a reduction in sugar-sweetened beverage consumption on the burden of type 2 diabetes in Brazil: A modeling study.
Nucci LB; Rinaldi AEM; Ramos AF; Itria A; Enes CC
Diabetes Res Clin Pract; 2022 Oct; 192():110087. PubMed ID: 36130646
[TBL] [Abstract][Full Text] [Related]
9. Health and economic burden of disease of sugar-sweetened beverage consumption in four Latin American and Caribbean countries: a modelling study.
Alcaraz A; Bardach AE; Espinola N; Perelli L; Rodriguez Cairoli F; La Foucade A; de Mello Vianna CM; Guevara G; Gittens-Baynes KA; Johns P; Beharry V; Balán DJ; Palacios A; Augustovski F; Pichon-Riviere A
BMJ Open; 2023 Feb; 13(2):e062809. PubMed ID: 36750287
[TBL] [Abstract][Full Text] [Related]
10. [Trends of burden on ischemic heart disease and epidemiological transition of related risk factors in China, 1990-2017].
Wang CR; Meng XF; Wang CP; Liu SW
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1703-1709. PubMed ID: 33297630
[No Abstract] [Full Text] [Related]
11. The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago.
La Foucade A; Laptiste C; Alcaraz A; Theodore K; Cumberbatch A; Gittens-Baynes KA; Beharry V; Gabriel S; Metivier C; Edwards-Wescott P; Bethelmie D
Nutr Health; 2023 Feb; ():2601060231156117. PubMed ID: 36775945
[TBL] [Abstract][Full Text] [Related]
12. Sugar sweetened beverages attributable disease burden and the potential impact of policy interventions: a systematic review of epidemiological and decision models.
Alcaraz A; Pichon-Riviere A; Palacios A; Bardach A; Balan DJ; Perelli L; Augustovski F; Ciapponi A
BMC Public Health; 2021 Jul; 21(1):1460. PubMed ID: 34315428
[TBL] [Abstract][Full Text] [Related]
13. Mortality attributable to sugar sweetened beverages consumption in Mexico: an update.
Braverman-Bronstein A; Camacho-García-Formentí D; Zepeda-Tello R; Cudhea F; Singh GM; Mozaffarian D; Barrientos-Gutierrez T
Int J Obes (Lond); 2020 Jun; 44(6):1341-1349. PubMed ID: 31822805
[TBL] [Abstract][Full Text] [Related]
14. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
; Murray CJ; Barber RM; Foreman KJ; Abbasoglu Ozgoren A; Abd-Allah F; Abera SF; Aboyans V; Abraham JP; Abubakar I; Abu-Raddad LJ; Abu-Rmeileh NM; Achoki T; Ackerman IN; Ademi Z; Adou AK; Adsuar JC; Afshin A; Agardh EE; Alam SS; Alasfoor D; Albittar MI; Alegretti MA; Alemu ZA; Alfonso-Cristancho R; Alhabib S; Ali R; Alla F; Allebeck P; Almazroa MA; Alsharif U; Alvarez E; Alvis-Guzman N; Amare AT; Ameh EA; Amini H; Ammar W; Anderson HR; Anderson BO; Antonio CA; Anwari P; Arnlöv J; Arsic Arsenijevic VS; Artaman A; Asghar RJ; Assadi R; Atkins LS; Avila MA; Awuah B; Bachman VF; Badawi A; Bahit MC; Balakrishnan K; Banerjee A; Barker-Collo SL; Barquera S; Barregard L; Barrero LH; Basu A; Basu S; Basulaiman MO; Beardsley J; Bedi N; Beghi E; Bekele T; Bell ML; Benjet C; Bennett DA; Bensenor IM; Benzian H; Bernabé E; Bertozzi-Villa A; Beyene TJ; Bhala N; Bhalla A; Bhutta ZA; Bienhoff K; Bikbov B; Biryukov S; Blore JD; Blosser CD; Blyth FM; Bohensky MA; Bolliger IW; Bora Başara B; Bornstein NM; Bose D; Boufous S; Bourne RR; Boyers LN; Brainin M; Brayne CE; Brazinova A; Breitborde NJ; Brenner H; Briggs AD; Brooks PM; Brown JC; Brugha TS; Buchbinder R; Buckle GC; Budke CM; Bulchis A; Bulloch AG; Campos-Nonato IR; Carabin H; Carapetis JR; Cárdenas R; Carpenter DO; Caso V; Castañeda-Orjuela CA; Castro RE; Catalá-López F; Cavalleri F; Çavlin A; Chadha VK; Chang JC; Charlson FJ; Chen H; Chen W; Chiang PP; Chimed-Ochir O; Chowdhury R; Christensen H; Christophi CA; Cirillo M; Coates MM; Coffeng LE; Coggeshall MS; Colistro V; Colquhoun SM; Cooke GS; Cooper C; Cooper LT; Coppola LM; Cortinovis M; Criqui MH; Crump JA; Cuevas-Nasu L; Danawi H; Dandona L; Dandona R; Dansereau E; Dargan PI; Davey G; Davis A; Davitoiu DV; Dayama A; De Leo D; Degenhardt L; Del Pozo-Cruz B; Dellavalle RP; Deribe K; Derrett S; Des Jarlais DC; Dessalegn M; Dharmaratne SD; Dherani MK; Diaz-Torné C; Dicker D; Ding EL; Dokova K; Dorsey ER; Driscoll TR; Duan L; Duber HC; Ebel BE; Edmond KM; Elshrek YM; Endres M; Ermakov SP; Erskine HE; Eshrati B; Esteghamati A; Estep K; Faraon EJ; Farzadfar F; Fay DF; Feigin VL; Felson DT; Fereshtehnejad SM; Fernandes JG; Ferrari AJ; Fitzmaurice C; Flaxman AD; Fleming TD; Foigt N; Forouzanfar MH; Fowkes FG; Paleo UF; Franklin RC; Fürst T; Gabbe B; Gaffikin L; Gankpé FG; Geleijnse JM; Gessner BD; Gething P; Gibney KB; Giroud M; Giussani G; Gomez Dantes H; Gona P; González-Medina D; Gosselin RA; Gotay CC; Goto A; Gouda HN; Graetz N; Gugnani HC; Gupta R; Gupta R; Gutiérrez RA; Haagsma J; Hafezi-Nejad N; Hagan H; Halasa YA; Hamadeh RR; Hamavid H; Hammami M; Hancock J; Hankey GJ; Hansen GM; Hao Y; Harb HL; Haro JM; Havmoeller R; Hay SI; Hay RJ; Heredia-Pi IB; Heuton KR; Heydarpour P; Higashi H; Hijar M; Hoek HW; Hoffman HJ; Hosgood HD; Hossain M; Hotez PJ; Hoy DG; Hsairi M; Hu G; Huang C; Huang JJ; Husseini A; Huynh C; Iannarone ML; Iburg KM; Innos K; Inoue M; Islami F; Jacobsen KH; Jarvis DL; Jassal SK; Jee SH; Jeemon P; Jensen PN; Jha V; Jiang G; Jiang Y; Jonas JB; Juel K; Kan H; Karch A; Karema CK; Karimkhani C; Karthikeyan G; Kassebaum NJ; Kaul A; Kawakami N; Kazanjan K; Kemp AH; Kengne AP; Keren A; Khader YS; Khalifa SE; Khan EA; Khan G; Khang YH; Kieling C; Kim D; Kim S; Kim Y; Kinfu Y; Kinge JM; Kivipelto M; Knibbs LD; Knudsen AK; Kokubo Y; Kosen S; Krishnaswami S; Kuate Defo B; Kucuk Bicer B; Kuipers EJ; Kulkarni C; Kulkarni VS; Kumar GA; Kyu HH; Lai T; Lalloo R; Lallukka T; Lam H; Lan Q; Lansingh VC; Larsson A; Lawrynowicz AE; Leasher JL; Leigh J; Leung R; Levitz CE; Li B; Li Y; Li Y; Lim SS; Lind M; Lipshultz SE; Liu S; Liu Y; Lloyd BK; Lofgren KT; Logroscino G; Looker KJ; Lortet-Tieulent J; Lotufo PA; Lozano R; Lucas RM; Lunevicius R; Lyons RA; Ma S; Macintyre MF; Mackay MT; Majdan M; Malekzadeh R; Marcenes W; Margolis DJ; Margono C; Marzan MB; Masci JR; Mashal MT; Matzopoulos R; Mayosi BM; Mazorodze TT; Mcgill NW; Mcgrath JJ; Mckee M; Mclain A; Meaney PA; Medina C; Mehndiratta MM; Mekonnen W; Melaku YA; Meltzer M; Memish ZA; Mensah GA; Meretoja A; Mhimbira FA; Micha R; Miller TR; Mills EJ; Mitchell PB; Mock CN; Mohamed Ibrahim N; Mohammad KA; Mokdad AH; Mola GL; Monasta L; Montañez Hernandez JC; Montico M; Montine TJ; Mooney MD; Moore AR; Moradi-Lakeh M; Moran AE; Mori R; Moschandreas J; Moturi WN; Moyer ML; Mozaffarian D; Msemburi WT; Mueller UO; Mukaigawara M; Mullany EC; Murdoch ME; Murray J; Murthy KS; Naghavi M; Naheed A; Naidoo KS; Naldi L; Nand D; Nangia V; Narayan KM; Nejjari C; Neupane SP; Newton CR; Ng M; Ngalesoni FN; Nguyen G; Nisar MI; Nolte S; Norheim OF; Norman RE; Norrving B; Nyakarahuka L; Oh IH; Ohkubo T; Ohno SL; Olusanya BO; Opio JN; Ortblad K; Ortiz A; Pain AW; Pandian JD; Panelo CI; Papachristou C; Park EK; Park JH; Patten SB; Patton GC; Paul VK; Pavlin BI; Pearce N; Pereira DM; Perez-Padilla R; Perez-Ruiz F; Perico N; Pervaiz A; Pesudovs K; Peterson CB; Petzold M; Phillips MR; Phillips BK; Phillips DE; Piel FB; Plass D; Poenaru D; Polinder S; Pope D; Popova S; Poulton RG; Pourmalek F; Prabhakaran D; Prasad NM; Pullan RL; Qato DM; Quistberg DA; Rafay A; Rahimi K; Rahman SU; Raju M; Rana SM; Razavi H; Reddy KS; Refaat A; Remuzzi G; Resnikoff S; Ribeiro AL; Richardson L; Richardus JH; Roberts DA; Rojas-Rueda D; Ronfani L; Roth GA; Rothenbacher D; Rothstein DH; Rowley JT; Roy N; Ruhago GM; Saeedi MY; Saha S; Sahraian MA; Sampson UK; Sanabria JR; Sandar L; Santos IS; Satpathy M; Sawhney M; Scarborough P; Schneider IJ; Schöttker B; Schumacher AE; Schwebel DC; Scott JG; Seedat S; Sepanlou SG; Serina PT; Servan-Mori EE; Shackelford KA; Shaheen A; Shahraz S; Shamah Levy T; Shangguan S; She J; Sheikhbahaei S; Shi P; Shibuya K; Shinohara Y; Shiri R; Shishani K; Shiue I; Shrime MG; Sigfusdottir ID; Silberberg DH; Simard EP; Sindi S; Singh A; Singh JA; Singh L; Skirbekk V; Slepak EL; Sliwa K; Soneji S; Søreide K; Soshnikov S; Sposato LA; Sreeramareddy CT; Stanaway JD; Stathopoulou V; Stein DJ; Stein MB; Steiner C; Steiner TJ; Stevens A; Stewart A; Stovner LJ; Stroumpoulis K; Sunguya BF; Swaminathan S; Swaroop M; Sykes BL; Tabb KM; Takahashi K; Tandon N; Tanne D; Tanner M; Tavakkoli M; Taylor HR; Te Ao BJ; Tediosi F; Temesgen AM; Templin T; Ten Have M; Tenkorang EY; Terkawi AS; Thomson B; Thorne-Lyman AL; Thrift AG; Thurston GD; Tillmann T; Tonelli M; Topouzis F; Toyoshima H; Traebert J; Tran BX; Trillini M; Truelsen T; Tsilimbaris M; Tuzcu EM; Uchendu US; Ukwaja KN; Undurraga EA; Uzun SB; Van Brakel WH; Van De Vijver S; van Gool CH; Van Os J; Vasankari TJ; Venketasubramanian N; Violante FS; Vlassov VV; Vollset SE; Wagner GR; Wagner J; Waller SG; Wan X; Wang H; Wang J; Wang L; Warouw TS; Weichenthal S; Weiderpass E; Weintraub RG; Wenzhi W; Werdecker A; Westerman R; Whiteford HA; Wilkinson JD; Williams TN; Wolfe CD; Wolock TM; Woolf AD; Wulf S; Wurtz B; Xu G; Yan LL; Yano Y; Ye P; Yentür GK; Yip P; Yonemoto N; Yoon SJ; Younis MZ; Yu C; Zaki ME; Zhao Y; Zheng Y; Zonies D; Zou X; Salomon JA; Lopez AD; Vos T
Lancet; 2015 Nov; 386(10009):2145-91. PubMed ID: 26321261
[TBL] [Abstract][Full Text] [Related]
15. Modeling the potential impact of a sugar-sweetened beverage tax on ischemic heart disease and stroke in Brazil.
Rinaldi AEM; Nucci LB; Enes CC
J Public Health (Oxf); 2024 May; ():. PubMed ID: 38798018
[TBL] [Abstract][Full Text] [Related]
16. Sugar-sweetened beverages consumption among New Zealand children aged 8-12 years: a cross sectional study of sources and associates/correlates of consumption.
Smirk E; Mazahery H; Conlon CA; Beck KL; Gammon C; Mugridge O; von Hurst PR
BMC Public Health; 2021 Dec; 21(1):2277. PubMed ID: 34903202
[TBL] [Abstract][Full Text] [Related]
17. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
[TBL] [Abstract][Full Text] [Related]
18. The burden of disease and economic impact of sugar-sweetened beverages' consumption in Argentina: A modeling study.
Bardach AE; Espínola N; Cairoli FR; Perelli L; Balan D; Palacios A; Augustovski F; Pichón-Riviere A; Alcaraz AO
PLoS One; 2023; 18(2):e0279978. PubMed ID: 36821592
[TBL] [Abstract][Full Text] [Related]
19. Regional Differences in Sugar-Sweetened Beverage Intake among US Adults.
Park S; McGuire LC; Galuska DA
J Acad Nutr Diet; 2015 Dec; 115(12):1996-2002. PubMed ID: 26231057
[TBL] [Abstract][Full Text] [Related]
20. Nutrition related non-communicable diseases and sugar sweetened beverage policies: a landscape analysis in Zambia.
Mukanu MM; Abdool Karim S; Hofman K; Erzse A; Thow AM
Glob Health Action; 2021 Jan; 14(1):1872172. PubMed ID: 33876714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
